2026/03/27
Shandong Xinbo helps Class 1.1 pediatric fever patch get approved for clinical trials
According to the official website of the Center for Drug Evaluation of the National Medical Products Administration and public information, Shandong Xinbo Pharmaceutical Research Co., Ltd. (hereinafter referred to as "Shandong Xinbo") assisted the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, in obtaining implied approval for the clinical trial of a new drug, "Magui Antipyretic Patch" (acceptance number: CXZL2500136)....
